- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
SLIDESHOW: Recent Data from LEO Pharma on Chronic Hand Eczema
Author(s):
Key Takeaways
- LEO Pharma's studies reveal significant gaps in education, treatment, and diagnosis of chronic hand eczema (CHE).
- 65% of dermatology providers acknowledge a lack of understanding of CHE, highlighting the need for improved education.
Global studies from LEO Pharma highlight the diagnostic gaps, quality-of-life burdens, and treatment landscape for patients with CHE.
LEO Pharma has recently conducted several studies on the impact of chronic hand eczema (CHE). These include the Chronic Hand Eczema epidemiology, Care, and Knowledge of real-life burden, or CHECK study1, the Real-World trEatment & mAnagement of chronic hand eczema in cLinical practice, or RWEAL study2, and the latest survey conducted by Ipsos.3
According to one survey, 65% of dermatology providers surveyed agree there is a lack of education and understanding of CHE. Dermatology Times is breaking down the major findings of these studies, which shed some light on the treatment gaps, diagnostic challenges, and levels of disease burden in patients with moderate to severe CHE.
To read more about research and expert insights into hand eczema, explore our interactive digital supplement featuring an exclusive deep-dive into the state and future of chronic hand eczema care.
References
1. Apfelbacher C, Bewley A, Molin S, et al. Prevalence of Chronic Hand Eczema in adults: A cross-sectional multi-national study of 60,000 respondents in the general population. Presented at the 2024 European Society of Contact Dermatitis (ESCD) congress; September 04-07 2024; Dresden, Germany. Poster presentation #3
2. Gimenez-Arnau AM, Bewley A, Apfelbacher C, et al. Physician-reported treatment patterns in Chronic Hand Eczema – results from the multinational RWEAL medical chart review. Presented at the 2024 European Society of Contact Dermatitis (ESCD) congress; September 04-07 2024; Dresden, Germany. Poster presentation #27
3. LEO Pharma survey: Dermatology providers say chronic hand eczema is widely misunderstood and inadequately managed. BioSpace. March 5, 2025. Accessed June 16, 2025. https://www.biospace.com/press-releases/leo-pharma-survey-dermatology-providers-say-chronic-hand-eczema-is-widely-misunderstood-and-inadequately-managed
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
